313 related articles for article (PubMed ID: 31333092)
1. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers.
Gorain B; Choudhury H; Yee GS; Bhattamisra SK
Curr Pharm Des; 2019; 25(26):2828-2841. PubMed ID: 31333092
[TBL] [Abstract][Full Text] [Related]
2. Adenosine receptors and cancer.
Fishman P; Bar-Yehuda S; Synowitz M; Powell JD; Klotz KN; Gessi S; Borea PA
Handb Exp Pharmacol; 2009; (193):399-441. PubMed ID: 19639290
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors.
Jamwal S; Mittal A; Kumar P; Alhayani DM; Al-Aboudi A
Curr Pharm Des; 2019; 25(26):2892-2905. PubMed ID: 31333104
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potency of pharmacological adenosine receptors agonist/antagonist on cancer cell apoptosis in tumor microenvironment, current status, and perspectives.
Soleimani A; Bahreyni A; Roshan MK; Soltani A; Ryzhikov M; Shafiee M; Soukhtanloo M; Jaafari MR; Mashkani B; Hassanian SM
J Cell Physiol; 2019 Mar; 234(3):2329-2336. PubMed ID: 30191994
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives.
Bahreyni A; Khazaei M; Rajabian M; Ryzhikov M; Avan A; Hassanian SM
J Pharm Pharmacol; 2018 Feb; 70(2):191-196. PubMed ID: 29057476
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor.
Ohana G; Bar-Yehuda S; Barer F; Fishman P
J Cell Physiol; 2001 Jan; 186(1):19-23. PubMed ID: 11147810
[TBL] [Abstract][Full Text] [Related]
7. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
Abbracchio MP; Cattabeni F
Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
[TBL] [Abstract][Full Text] [Related]
8. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
9. Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways.
Agarwal R; Agarwal P
Expert Opin Ther Targets; 2014 May; 18(5):527-39. PubMed ID: 24579961
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms.
Schiedel AC; Lacher SK; Linnemann C; Knolle PA; Müller CE
Purinergic Signal; 2013 Sep; 9(3):351-65. PubMed ID: 23359122
[TBL] [Abstract][Full Text] [Related]
11. P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
Borah P; Deka S; Mailavaram RP; Deb PK
Curr Pharm Des; 2019; 25(26):2792-2807. PubMed ID: 31333097
[TBL] [Abstract][Full Text] [Related]
12. Adenosine Receptors in Modulation of Central Nervous System Disorders.
Choudhury H; Chellappan DK; Sengupta P; Pandey M; Gorain B
Curr Pharm Des; 2019; 25(26):2808-2827. PubMed ID: 31309883
[TBL] [Abstract][Full Text] [Related]
13. Adenosine regulates tissue factor expression on endothelial cells.
Deguchi H; Takeya H; Urano H; Gabazza EC; Zhou H; Suzuki K
Thromb Res; 1998 Jul; 91(2):57-64. PubMed ID: 9722021
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Role of N
Petrelli R; Scortichini M; Kachler S; Boccella S; Cerchia C; Torquati I; Del Bello F; Salvemini D; Novellino E; Luongo L; Maione S; Jacobson KA; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2017 May; 60(10):4327-4341. PubMed ID: 28447789
[TBL] [Abstract][Full Text] [Related]
15. Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature.
Sousa JB; Fresco P; Diniz C; Goncalves J
Recent Pat Anticancer Drug Discov; 2018; 13(1):40-69. PubMed ID: 29119938
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation.
Liang BT; Haltiwanger B
Circ Res; 1995 Feb; 76(2):242-51. PubMed ID: 7834835
[TBL] [Abstract][Full Text] [Related]
17. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
Deb PK; Deka S; Borah P; Abed SN; Klotz KN
Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
[TBL] [Abstract][Full Text] [Related]
18. A
Tay AHM; Prieto-Díaz R; Neo S; Tong L; Chen X; Carannante V; Önfelt B; Hartman J; Haglund F; Majellaro M; Azuaje J; Garcia-Mera X; Brea JM; Loza MI; Jespers W; Gutierrez-de-Teran H; Sotelo E; Lundqvist A
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580926
[TBL] [Abstract][Full Text] [Related]
19. The role of receptor structure in determining adenosine receptor activity.
Olah ME; Stiles GL
Pharmacol Ther; 2000 Feb; 85(2):55-75. PubMed ID: 10722120
[TBL] [Abstract][Full Text] [Related]
20. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain.
Vincenzi F; Pasquini S; Borea PA; Varani K
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
